Focus boosting drugs not worth the risks, studies warn
Focus boosting drugs not worth the risks, studies warn
- August 12, 2019
- Sara Mednick, cog sci, Medical News Today, Aug. 12, 2019
-----
Yet, according to a new study by researchers from the University of California, Irvine, the nonmedical use of psychostimulants such as Adderall only brings short term benefits. The team found that in the long run, these drugs, in fact, negatively affect focus, working memory, and sleep quality, creating a vicious cycle. "Healthy individuals who use psychostimulants for cognitive enhancement may incur unintended costs to cognitive processes that depend on good sleep," warns lead author Lauren Whitehurst.
For the full story, please visit https://www.medicalnewstoday.com/articles/326023.php.
-----
Would you like to get more involved with the social sciences? Email us at communications@socsci.uci.edu to connect.
Related News Items
- Careet RightA common smartphone metric may be brain health's next frontier
- Careet RightWhy temperature plays a powerful role in sleep, and how cooling solutions can help
- Careet RightAre naps good for you? What sleep experts really want you to know
- Careet RightSip passionflower tea, take a 5-minute micronap and build an 'anxiety bag' -- plus 8 more health tips to help you have a great week
- Careet RightNapping for just 5 minutes can change the trajectory of your day. Here's how.